BROWSE BY STUDY TYPE OR CONFERENCE
All
- All
- MODEL VALIDATION
- CLINICAL VALIDATION
- AACR
- ASCO
- ASH
BROWSE BY YEAR
All
- All
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- Archive
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
Journal of Neuro-Oncology ,
Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.
ASCO Meeting Library,
Cellworks Omics Biology Model (CBM) to identify amplifications of chromosome 11p and 1p predict paclitaxel and carboplatin resistance.